Dexniguldipine (free base) | CAS# 120054-86-6 (free base)

MedKoo Cat#: 412196 | Name: Dexniguldipine free base

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Dexniguldipine (free base) is the (+)-enantiomer of the dihydropyridine derivate niguldipine. Dexniguldipine showed a binding affinity to the P-glycoprotein and therefore it is to be assumed to block the P-glycoprotein pumping mechanism and to modulate multidrug resistance. ( NCI)

Chemical Structure

Dexniguldipine free base

CAS#120054-86-6 (free base)

Theoretical Analysis

MedKoo Cat#: 412196

Name: Dexniguldipine free base

CAS#: 120054-86-6 (free base)

Chemical Formula: C36H39N3O6

Exact Mass: 609.2839

Molecular Weight: 609.72

Elemental Analysis: C, 70.92; H, 6.45; N, 6.89; O, 15.74

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

120054-86-6 (free base) 113145-70-3 (HCl)

Synonym

Dexniguldipine (free base);

IUPAC/Chemical Name

( )-(R)-3-(4,4-Diphenylpiperidino)propyl methyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate.

InChi Key

SVJMLYUFVDMUHP-MGBGTMOVSA-N

InChi Code

InChI=1S/C36H39N3O6/c1-25-31(34(40)44-3)33(27-12-10-17-30(24-27)39(42)43)32(26(2)37-25)35(41)45-23-11-20-38-21-18-36(19-22-38,28-13-6-4-7-14-28)29-15-8-5-9-16-29/h4-10,12-17,24,33,37H,11,18-23H2,1-3H3/t33-/m1/s1

SMILES Code

O=C(C1=C(C)NC(C)=C(C(OCCCN2CCC(C3=CC=CC=C3)(C4=CC=CC=C4)CC2)=O)[C@@H]1C5=CC=CC([N+]([O-])=O)=C5)OC

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>3 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 609.72 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Niklasson M, Maddalo G, Sramkova Z, Mutlu E, Wee S, Sekyrova P, Schmidt L, Fritz N, Dehnisch I, Kyriatzis G, Krafcikova M, Carson BB, Feenstra JM, Marinescu VD, Segerman A, Haraldsson M, Gustavsson AL, Hammarström LG, Jenmalm Jensen A, Uhrbom L, Altelaar AF, Linnarsson S, Uhlén P, Trantirek L, Vincent CT, Nelander S, Enger PØ, Andäng M. Membrane-Depolarizing Channel Blockers Induce Selective Glioma Cell Death by Impairing Nutrient Transport and Unfolded Protein/Amino Acid Responses. Cancer Res. 2017 Apr 1;77(7):1741-1752. doi: 10.1158/0008-5472.CAN-16-2274. Epub 2017 Jan 13. PMID: 28087597. 2: Kreiner G, Roman A, Zelek-Molik A, Kowalska M, Nalepa I. A lack of α1A-adrenergic receptor-mediated antidepressant-like effects of S-(+)-niguldipine and B8805-033 in the forced swim test. Behav Pharmacol. 2016 Jun;27(4):397-401. doi: 10.1097/FBP.0000000000000204. PMID: 26588212. 3: Enyeart JJ, Enyeart JA. Adrenal fasciculata cells express T-type and rapidly and slowly activating L-type Ca2+ channels that regulate cortisol secretion. Am J Physiol Cell Physiol. 2015 Jun 1;308(11):C899-918. doi: 10.1152/ajpcell.00002.2015. Epub 2015 Mar 18. PMID: 25788571; PMCID: PMC4451351. 4: Berchtold MW, Villalobo A. The many faces of calmodulin in cell proliferation, programmed cell death, autophagy, and cancer. Biochim Biophys Acta. 2014 Feb;1843(2):398-435. doi: 10.1016/j.bbamcr.2013.10.021. Epub 2013 Nov 2. PMID: 24188867. 5: van Doorn WG, Çelikel FG, Pak C, Harkema H. Delay of iris flower senescence by cytokinins and jasmonates. Physiol Plant. 2013 May;148(1):105-20. doi: 10.1111/j.1399-3054.2012.01690.x. Epub 2012 Oct 9. PMID: 22974423. 6: Uesawa Y, Mohri K. Quantitative structure-interaction relationship analysis of 1,4-dihydropyridine drugs in concomitant administration with grapefruit juice. Pharmazie. 2012 Mar;67(3):195-201. PMID: 22530299. 7: Palmeira A, Sousa E, Vasconcelos MH, Pinto MM. Three decades of P-gp inhibitors: skimming through several generations and scaffolds. Curr Med Chem. 2012;19(13):1946-2025. doi: 10.2174/092986712800167392. PMID: 22257057. 8: de Almeida Kiguti LR, Pupo AS. Investigation of the effects of α1-adrenoceptor antagonism and L-type calcium channel blockade on ejaculation and vas deferens and seminal vesicle contractility in vitro. J Sex Med. 2012 Jan;9(1):159-68. doi: 10.1111/j.1743-6109.2011.02410.x. Epub 2011 Aug 2. PMID: 21810189. 9: Mehdipour AR, Javidnia K, Hemmateenejad B, Amirghofran Z, Miri R. Dihydropyridine derivatives to overcome atypical multidrug resistance: design, synthesis, QSAR studies, and evaluation of their cytotoxic and pharmacological activities. Chem Biol Drug Des. 2007 Oct;70(4):337-46. doi: 10.1111/j.1747-0285.2007.00569.x. PMID: 17937779. 10: Vinci MC, Bellik L, Filippi S, Ledda F, Parenti A. Trophic effects induced by alpha1D-adrenoceptors on endothelial cells are potentiated by hypoxia. Am J Physiol Heart Circ Physiol. 2007 Oct;293(4):H2140-7. doi: 10.1152/ajpheart.00390.2007. Epub 2007 Jul 27. PMID: 17660397. 11: Liu H, Enyeart JA, Enyeart JJ. Potent inhibition of native TREK-1 K+ channels by selected dihydropyridine Ca2+ channel antagonists. J Pharmacol Exp Ther. 2007 Oct;323(1):39-48. doi: 10.1124/jpet.107.125245. Epub 2007 Jul 10. PMID: 17622574. 12: Yeh YH, Ehrlich JR, Qi X, Hébert TE, Chartier D, Nattel S. Adrenergic control of a constitutively active acetylcholine-regulated potassium current in canine atrial cardiomyocytes. Cardiovasc Res. 2007 Jun 1;74(3):406-15. doi: 10.1016/j.cardiores.2007.01.020. Epub 2007 Feb 12. PMID: 17343836. 13: Perlstein EO, Ruderfer DM, Roberts DC, Schreiber SL, Kruglyak L. Genetic basis of individual differences in the response to small-molecule drugs in yeast. Nat Genet. 2007 Apr;39(4):496-502. doi: 10.1038/ng1991. Epub 2007 Mar 4. PMID: 17334364. 14: Pérez-Tomás R. Multidrug resistance: retrospect and prospects in anti-cancer drug treatment. Curr Med Chem. 2006;13(16):1859-76. doi: 10.2174/092986706777585077. PMID: 16842198. 15: Pedemonte N, Diena T, Caci E, Nieddu E, Mazzei M, Ravazzolo R, Zegarra-Moran O, Galietta LJ. Antihypertensive 1,4-dihydropyridines as correctors of the cystic fibrosis transmembrane conductance regulator channel gating defect caused by cystic fibrosis mutations. Mol Pharmacol. 2005 Dec;68(6):1736-46. doi: 10.1124/mol.105.015149. Epub 2005 Sep 8. PMID: 16150931. 16: Zhou XF, Coburn RA, Morris ME. Effects of new 4-aryl-1,4-dihydropyridines and 4-arylpyridines on drug efflux mediated by multidrug resistance-associated protein 1. J Pharm Sci. 2005 Oct;94(10):2256-65. doi: 10.1002/jps.20406. PMID: 16136554. 17: Zhou XF, Wang Q, Coburn RA, Morris ME. A high-performance liquid chromatographic method for determination of the niguldipine analogue DHP-014. Biomed Chromatogr. 2006 Jan;20(1):48-53. doi: 10.1002/bmc.526. PMID: 15954160. 18: Zhou XF, Yang X, Wang Q, Coburn RA, Morris ME. Effects of dihydropyridines and pyridines on multidrug resistance mediated by breast cancer resistance protein: in vitro and in vivo studies. Drug Metab Dispos. 2005 Aug;33(8):1220-8. doi: 10.1124/dmd.104.003558. Epub 2005 May 20. PMID: 15908473. 19: Zhou XF, Zhang L, Tseng E, Scott-Ramsay E, Schentag JJ, Coburn RA, Morris ME. New 4-aryl-1,4-dihydropyridines and 4-arylpyridines as P-glycoprotein inhibitors. Drug Metab Dispos. 2005 Mar;33(3):321-8. doi: 10.1124/dmd.104.002089. Epub 2004 Dec 7. PMID: 15585608. 20: Kułak W, Sobaniec W, Wojtal K, Czuczwar SJ. Calcium modulation in epilepsy. Pol J Pharmacol. 2004 Jan-Feb;56(1):29-41. PMID: 15047975.